2004
DOI: 10.1097/01.meg.0000108337.41221.08
|View full text |Cite
|
Sign up to set email alerts
|

Crohn's disease in the over-60 age group

Abstract: In Brittany, the age specific incidence, clinical features, and prognosis of CD among the elderly are comparable to those in younger individuals. Colon involvement is more common. Concomitant diverticular disease is common and should prompt a search for CD lesions at other sites to confirm the diagnosis. Older patients are less likely to require immunosuppressants or admission for flares.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

9
39
3
3

Year Published

2006
2006
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(54 citation statements)
references
References 40 publications
9
39
3
3
Order By: Relevance
“…Similarly, comparable incidence rates for CD have been reported from France between 1994 and 1997 [47] . The annual incidence rate is 2.5/10 5 , with a higher proportion of colonic disease.…”
Section: Most Of the Published Data Come From The Unitedsupporting
confidence: 74%
“…Similarly, comparable incidence rates for CD have been reported from France between 1994 and 1997 [47] . The annual incidence rate is 2.5/10 5 , with a higher proportion of colonic disease.…”
Section: Most Of the Published Data Come From The Unitedsupporting
confidence: 74%
“…[25][26][27] Data on the disease course of EO IBD are mainly derived from small selected referral center cohorts, some collected decades ago. [28][29][30][31][32][33][34][35][36][37][38][39] Recent population-based data from the Hungarian registry and the French EPIMAD registry suggested a somewhat milder course of IBD diagnosed at older age, yet the number of elderly patients was limited 40 or data from the corresponding adult population were lacking, 41 impeding a direct comparison. To balance benefit and risk of treatment strategies in the elderly population, information on the current treatment strategy and disease outcome is needed, preferably from a large unselected population of patients with IBD studied in direct comparison to AO disease.…”
mentioning
confidence: 99%
“…Polymorphisms that have been reported to increase (308G/A) or decrease circulating TNF-␣ (238G/A, 857 C/T, 863 C/A) (27)(28)(29)(30)(31)(32)(33), as well as playing a possible role in disease phenotype and susceptibility (27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39). The 857C/T and 863C/A polymorphisms appear to be located at transcription factor binding sites (32,34,35).…”
mentioning
confidence: 99%